FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

28395311000001100: Ledipasvir 90mg / Sofosbuvir 400mg tablets (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 07-Jan 2015. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
1844081000001113 Ledipasvir 90mg / Sofosbuvir 400mg tablets en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
1844091000001110 Ledipasvir 90mg / Sofosbuvir 400mg tablets (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module


1 descendants. Search Descendants:

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Ledipasvir 90mg / Sofosbuvir 400mg tablets Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) ontology form and route tablet.oral ontology form and route true Inferred relationship Existential restriction modifier
Ledipasvir 90mg / Sofosbuvir 400mg tablets Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) route of administration Oral route true Inferred relationship Existential restriction modifier
Ledipasvir 90mg / Sofosbuvir 400mg tablets Has NHS dm+d (dictionary of medicines and devices) dose form indicator Discrete dose form indicator true Inferred relationship Existential restriction modifier
Ledipasvir 90mg / Sofosbuvir 400mg tablets Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Ledipasvir 90mg / Sofosbuvir 400mg tablets Is a Ledipasvir + Sofosbuvir true Inferred relationship Existential restriction modifier
Ledipasvir 90mg / Sofosbuvir 400mg tablets Plays role Antiviral therapeutic role true Inferred relationship Existential restriction modifier
Ledipasvir 90mg / Sofosbuvir 400mg tablets Is a Ledipasvir + Sofosbuvir false Inferred relationship Existential restriction modifier
Ledipasvir 90mg / Sofosbuvir 400mg tablets Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Ledipasvir 90mg / Sofosbuvir 400mg tablets Has specific active ingredient Ledipasvir false Inferred relationship Existential restriction modifier
Ledipasvir 90mg / Sofosbuvir 400mg tablets Has specific active ingredient Sofosbuvir false Inferred relationship Existential restriction modifier
Ledipasvir 90mg / Sofosbuvir 400mg tablets VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Ledipasvir 90mg / Sofosbuvir 400mg tablets VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Ledipasvir 90mg / Sofosbuvir 400mg tablets Is a Virtual medicinal product true Inferred relationship Existential restriction modifier
Ledipasvir 90mg / Sofosbuvir 400mg tablets Has active ingredient Substance with antiviral mechanism of action false Inferred relationship Existential restriction modifier
Ledipasvir 90mg / Sofosbuvir 400mg tablets Has specific active ingredient Ledipasvir true Inferred relationship Existential restriction modifier
Ledipasvir 90mg / Sofosbuvir 400mg tablets Has specific active ingredient Sofosbuvir true Inferred relationship Existential restriction modifier
Ledipasvir 90mg / Sofosbuvir 400mg tablets Has manufactured dose form Tablet false Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Harvoni 90mg/400mg tablets (Gilead Sciences Ltd) Is a True Ledipasvir 90mg / Sofosbuvir 400mg tablets Inferred relationship Existential restriction modifier
Ledipasvir 90mg / Sofosbuvir 400mg tablets 28 tablet Has VMP True Ledipasvir 90mg / Sofosbuvir 400mg tablets Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start